Prospective evaluation of rotating chemotherapy in advanced breast cancer : An Eastern Cooperative Oncology Group Trial*
Obesity, estrogen production, and tumor estrogen receptors in women with carcinoma of the breast*
Adjuvant chemotherapy (CMF) for breast carcinoma : Patient's compliance and total dose achieved
Phase II clinical evaluation of AZQ in metastatic breast cancer
Phase II clinical trial of cis -dichlorodiammineplatinum in gastric cancer
Phase II clinical evaluation of intravenous 4′-(9-acridinylamino) methanesulfon- m -anisidide in colorectal cancer
Phase II evaluation of dihydroxyanthracenedione (DHAD, NSC 301739) in patients with metastatic colorectal cancer
Phase II evaluation of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperi-dyl)-1-nitrosourea (PCNU, NSC 95466) in patients with metastatic colorectal cancer
Natural cytotoxicity in patients undergoing radiation therapy
Investigation in the role of surgery, chemotherapy, and radiation in a murine osteosarcoma model
Combination chemotherapy for advanced sarcomas of bone and mesothelioma utilizing rubidazone and DTIC: : A Southwest Oncology Group Study
Osteosarcoma—A complication of chemotherapy for Hodgkin's disease in children
Clinical evaluation of a new anthracycline antibiotic, aclacinomycin-A, in patients with advanced malignant lymphoma
Treatment of advanced ovarian cancer with cis -dichlorodiammine platinum in combination with cyclophosphamide : An E.C.O.G. Pilot Study
The use of misonidazole in association with a three-fractions per day regimen in advanced head and neck epidermoid cancer : A pilot study
Phase II evaluation of 1-(2-chloroethyl)-3-(2,6-dioxo-(piperidyl)-1 nitrosourea (PCNU NSC-95466) in patients with advanced carcinoma of the lung
Protracted ambulatory venous infusion of 5-fluorouracil
A phase I-II study of continuous 5-day infusion mitomycin-C
Mini-dose weekly adriamycin therapy for patients with advanced malignant disease at increased risk for adriamycin toxicity
The quality of which life?
Book Reviews